Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-03-06 @ 12:34 AM
Study NCT ID:
NCT01856218
Status:
COMPLETED
Last Update Posted:
2019-01-04
First Post:
2013-05-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UX003-CL201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None